Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206 Pharmaceutical Investing
Merck to Hold Second-Quarter 2021 Sales and Earnings Conference Call on July 29 Pharmaceutical Investing
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients Medical Device Investing
Merck Animal Health Survey Reveals Pet Owners Need Advice Navigating Their Pets' Transition to Normalcy Pharmaceutical Investing
OneTen Launches Technology Platform to Create and Enable One Million Career Opportunities for Black Talent Over the Next 10 Years Pharmaceutical Investing
Upadacitinib Met the Primary and All Secondary Endpoints in the 52-Week Phase 3 Maintenance Study in Ulcerative Colitis Patients Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo Plus Yervoy for the Treatment of Mismatch Repair Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer After Prior Chemotherapy Biotech Investing
European Commission Approves Merck's KEYTRUDA® Plus Chemotherapy for Certain Patients With Esophageal Cancer or HER2-Negative Gastroesophageal Junction Adenocarcinoma Pharmaceutical Investing
